Patterns of bone mineral density testing
暂无分享,去创建一个
J. Avorn | J. Katz | D. Solomon | J. Finkelstein | D. Cabral | Charles A. Morris | Hailu Cheng | J. Katz
[1] L. Papa,et al. Physician characteristics associated with the use of bone densitometry , 1997, Journal of General Internal Medicine.
[2] C. Cooper,et al. Guidelines for diagnosis and management of osteoporosis , 2005, Osteoporosis International.
[3] D. Shewmon,et al. Hip fracture patients are not treated for osteoporosis: a call to action. , 2002, Arthritis and rheumatism.
[4] J. Katz,et al. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. , 2002, Arthritis and rheumatism.
[5] C. Ambrose,et al. Undertreatment of osteoporosis in men with hip fracture. , 2002, Archives of internal medicine.
[6] J. Peipert,et al. Screening for Osteoporosis in Postmenopausal Women: Recommendations and Rationale , 2002, Annals of Internal Medicine.
[7] P. Ebeling,et al. Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit , 2002, The Medical journal of Australia.
[8] L. Espinoza,et al. Soluble TNF receptor treatment does not affect raised TGFβ levels in RA , 2002 .
[9] Mahmood Puzirandeh. Does patient partnership in continuing medical education (CME) improve the outcome in osteoporosis management? , 2002 .
[10] O. Geling,et al. Missed opportunities for prevention of osteoporotic fracture. , 2002, Archives of internal medicine.
[11] Pamela A. Shaw,et al. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998. , 2002, Urology.
[12] J. Compston,et al. Guidelines on the management of osteoporosis associated with chronic liver disease , 2002, Gut.
[13] M. Carnes,et al. Outcomes and Secondary Prevention Strategies for Male Hip Fractures , 2002, The Annals of pharmacotherapy.
[14] B. Gudbjornsson,et al. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice , 2002, Annals of the rheumatic diseases.
[15] J. Nolla,et al. Usefulness of bone densitometry in postmenopausal women with clinically diagnosed vertebral fractures , 2002, Annals of the rheumatic diseases.
[16] Jacques P. Brown,et al. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[17] P. Hoffmeyer,et al. An Osteoporosis Clinical Pathway for the Medical Management of Patients with Low-Trauma Fracture , 2002, Osteoporosis International.
[18] M. Ahern,et al. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. , 2001, The Journal of rheumatology.
[19] H. Rodbard,et al. American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. , 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[20] B. Ettinger,et al. Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. , 2001, The American journal of managed care.
[21] J. Allison,et al. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. , 2001, The Journal of rheumatology.
[22] J. Gurwitz,et al. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. , 2001, Archives of internal medicine.
[23] M. Ahern,et al. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital. , 2001, The Journal of rheumatology.
[24] M. Hochberg,et al. Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1996 .
[25] M. Hochberg,et al. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 Update: American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis , 2001 .
[26] D. Hosking,et al. An audit of current clinical practice in the management of osteoporosis in Nottingham. , 2000, Journal of public health medicine.
[27] J. Compston,et al. Prevention and Treatment of Osteoporosis: Clinical Guidelines and New Evidence , 2000, Journal of the Royal College of Physicians of London.
[28] E. Seely,et al. Provider characteristics: impact on bone density utilization at a health maintenance organization , 2000, Menopause.
[29] G. Hawker,et al. Patterns of use of the bone mineral density test in Ontario, 1992-1998. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[30] E. E. Hajcsar,et al. Investigation and treatment of osteoporosis in patients with fragility fractures. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[31] R. Sloane,et al. Expert Physician Recommendations and Current Practice Patterns for Evaluating and Treating Men with Osteoporotic Hip Fracture , 2000, Journal of the American Geriatrics Society.
[32] H. Perry,et al. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. , 2000, The American journal of medicine.
[33] W. Bilker,et al. Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*† , 2000, The Journal of bone and joint surgery. American volume.
[34] L. Moreland,et al. Practice Pattern Variation Among Internal Medicine Specialists in the Prevention of Glucocorticoid‐Induced Osteoporosis , 2000, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[35] P. Salkovskis,et al. The effect of nondirective questioning on women's decisions whether to undergo bone density screening: an experimental study. , 2000, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[36] J. Sibley,et al. Management of corticosteroid-induced osteoporosis. , 2000, Seminars in arthritis and rheumatism.
[37] M. Ruffin,et al. Predictors of Screening for Breast, Cervical, Colorectal, and Prostatic Cancer Among Community-Based Primary Care Practices , 2000, The Journal of the American Board of Family Medicine.
[38] G. Wood,et al. Osteoporosis Disease Management: Best Practices from the Penn State Geisinger Health System , 2000 .
[39] G. Hawker,et al. Use of Bone Densitometry by Ontario Family Physicians , 2000, Osteoporosis International.
[40] State-specific cholesterol screening trends--United States, 1991-1999. , 2000, MMWR. Morbidity and mortality weekly report.
[41] R. Feezor,et al. Prevention of corticosteroid-induced osteoporosis: results of a patient survey. , 1999, Arthritis and rheumatism.
[42] R. Rizzoli,et al. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. , 1999, Clinical therapeutics.
[43] R. Rizzoli,et al. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. , 1999, Clinical therapeutics.
[44] C. Cooper,et al. A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update , 1998, Journal of internal medicine.
[45] M. Morris,et al. Clinical Reporting to Primary Care Physicians Leads to Increased Use and Understanding of Bone Densitometry and Affects the Management of Osteoporosis , 1998, Annals of Internal Medicine.
[46] C. Cooper,et al. Management of male osteoporosis: report of the UK Consensus Group. , 1998, QJM : monthly journal of the Association of Physicians.
[47] M. Evans,et al. Clinical practice guidelines for the diagnosis and management of osteoporosis , 1997 .
[48] S. Hodgson. AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis. , 2011, The Journal of the Florida Medical Association.
[49] D. Hanley,et al. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 2. The use of bone density measurement in the diagnosis and management of osteoporosis. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[50] O Johnell,et al. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. , 1996, BMJ.
[51] U. P. S. T. Force. Guide to Clinical Preventive Services: Report of the U S Preventive Services Task Force , 1996 .
[52] S. Cummings,et al. Bone density at various sites for prediction of hip fractures , 1993, The Lancet.
[53] S Kamen,et al. The task force. , 1976, Journal of hospital dental practice.